Axillary Nodal Upstaging in cT1N0 Invasive Lobular Carcinoma: Assessing Sentinel Lymph Node Biopsy Omission Based on SOUND Trial Evidence
Posted inClinical Updates news Oncology

Axillary Nodal Upstaging in cT1N0 Invasive Lobular Carcinoma: Assessing Sentinel Lymph Node Biopsy Omission Based on SOUND Trial Evidence

This review evaluates whether sentinel lymph node biopsy omission, validated in SOUND and INSEMA trials, applies to cT1N0 invasive lobular carcinoma, highlighting nodal positivity rates, risk factors such as lymphovascular invasion, and clinical implications for tailored axillary management.